Founders Capital Management Medtronic PLC Transaction History

Founders Capital Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 20, 2022	BUY	$87.4 - $113.09 $5,768 - $7,463	66 Added 29.33%	291 $26,000
Q1 2021 Jun 09, 2021	SELL	$111.18 - $119.74 $25,015 - $26,941	-225 Reduced 50.0%	225 $27,000
Q1 2020 Apr 22, 2020	BUY	$72.92 - $121.3 $16,407 - $27,292	225 Added 100.0%	450 $42,000
Q2 2018 Jul 09, 2018	SELL	$77.48 - $87.83 $148,374 - $168,194	-1,915 Reduced 89.49%	225 $19,000
Q3 2017 Oct 17, 2017	BUY	$77.71 - $84.6 $166,299 - $181,044	2,140	2,140 $166,000

2,285

1.02B

8.05M

7.19M

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $115B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

Get notified when there are updates to the investment portfolio of Founders Capital Management, based on Form 13F filings with the SEC.

Stay updated on Founders Capital Management with notifications on news.